As a tumor suppressor, SIRT2 maintains genome stability and prevents oncogenic transformations by regulating the DNA damage response through deacetylating key components like ATRIP (ATR-interacting protein) and CDK9 (Cyclin-dependent kinase 9) [69,70]. Here, CDK9 is linked to neoplasm.